Home / Data / Women's Health Trial Tracker Women's Health Trial Tracker Women's Health Trial Tracker organizes records from ClinicalTrials.gov API v2 into a static table for transparent comparison. It preserves official source links and dates, marks missing enrichment, and adds deterministic grouping, change, recency, trend, or significance fields only where the documented inputs support them, without recommendations or unsupported claims.
Records 5,000
Last changed 10/10/2026
Update schedule 55 1 * * * UTC
Coverage 05/26/2000–10/09/2026 Record Record Date Vuga Group Change Status Recency Days Research Attention Score PORTEC-4a: Molecular Profile-based Versus Standard Adjuvant Radiotherapy in Endometrial Cancer 03/19/2018 INTERVENTIONAL not-comparable 3,127.75 0 ASA in Prevention of Ovarian Cancer (STICs and STONEs) 03/29/2018 INTERVENTIONAL not-comparable 3,117.75 0 Continuous Positive Airway Pressure (CPAP) for Sleep Apnea in Pregnancy 04/03/2018 INTERVENTIONAL not-comparable 3,112.75 0 Regional Radiotherapy in Biomarker Low-Risk Node Positive and T3N0 Breast Cancer 04/05/2018 INTERVENTIONAL not-comparable 3,110.75 0 MRI Characterization of Mammographically Detected DCIS 04/11/2018 OBSERVATIONAL not-comparable 3,104.75 0 Autologous Ovarian Tissue Transplantation 04/12/2018 INTERVENTIONAL not-comparable 3,103.75 0 Clinical Cohort Study on the Endocrinology and Vaginal/Endometrial Microbiome of the Luteal Phase in Assisted Reproduction 04/25/2018 OBSERVATIONAL not-comparable 3,090.75 0 LimPrOn: Limburg Pre-eclampsia Investigation 04/26/2018 INTERVENTIONAL not-comparable 3,089.75 0 Maternal Smoking Cessation and Pediatric Obesity Prevention 05/02/2018 INTERVENTIONAL not-comparable 3,083.75 0 Follow-up in Gynecological Cancer Survivors 05/04/2018 OBSERVATIONAL not-comparable 3,081.75 0 Maintenance Treatment With BGB-290 Versus Placebo in Participants With Platinum-sensitive Recurrent Ovarian Cancer 05/08/2018 INTERVENTIONAL not-comparable 3,077.75 0 A Study in Ovarian Cancer Patients Evaluating Rucaparib and Nivolumab as Maintenance Treatment Following Response to Front-Line Platinum-Based Chemotherapy 05/11/2018 INTERVENTIONAL not-comparable 3,074.75 0 Cranberry Tablets Versus Nitrofurantoin Prophylaxis for Urinary Tract Infection Prevention After Urogynecologic Surgery 05/14/2018 INTERVENTIONAL not-comparable 3,071.75 0 RNA Disruption Assay (RDA)-Breast Cancer Response Evaluation for Individualized Therapy 05/14/2018 INTERVENTIONAL not-comparable 3,071.75 0 Phase II Study of Atezolizumab + Bevacizumab in Endometrial Cancer 05/16/2018 INTERVENTIONAL not-comparable 3,069.75 0 Gestational Diabetes and Pharmacotherapy (GAP) 05/17/2018 INTERVENTIONAL not-comparable 3,068.75 0 Fulvestrant Plus Abemaciclib in Women With Advanced Low Grade Serous Carcinoma 05/22/2018 INTERVENTIONAL not-comparable 3,063.75 0 Induction Chemotherapy Followed by Standard Therapy in Cervical Cancer With Aortic Lymph Node Spread 05/23/2018 INTERVENTIONAL not-comparable 3,062.75 0 Ultrasound Identification Automation Study 05/24/2018 OBSERVATIONAL not-comparable 3,061.75 0 IORT Following Breast Conserving Surgery for Early Stage Breast Cancer Registry 05/25/2018 OBSERVATIONAL not-comparable 3,060.75 0 The DETECT Study: Discovery and Evaluation of Testing for Endometrial and Ovarian Cancer in Tampons 05/29/2018 OBSERVATIONAL not-comparable 3,056.75 0 Peri-Operative Immune Checkpoint Inhibition and Cryoablation in Women With Triple-negative Breast Cancer 06/06/2018 INTERVENTIONAL not-comparable 3,048.75 0 Diabetes Prevention Program With or Without Hunger Training in Helping to Lower Breast Cancer Risk in Obese Participants 06/06/2018 INTERVENTIONAL not-comparable 3,048.75 0 Quality of Life and Fertility of Patient With Deep Surgical Endometriosis: a Prospective Cohort 06/14/2018 OBSERVATIONAL not-comparable 3,040.75 0 Efficacy of Metoclopramide in Poor Ovarian Response IVF Patients 06/18/2018 INTERVENTIONAL not-comparable 3,036.75 0 A Registry of Intra-Operative Radiation Therapy (IORT) Using the Xoft ® Axxent ® eBx ™ System Patients 06/19/2018 OBSERVATIONAL not-comparable 3,035.75 0 Birth Cohort Study of China Medical University 06/19/2018 OBSERVATIONAL not-comparable 3,035.75 0 GammaPod Registry and Quality of Life Nomogram 06/19/2018 OBSERVATIONAL not-comparable 3,035.75 0 Study of REGN4018 (Ubamatamab) Administered Alone or in Combination With Cemiplimab in Adult Patients With Recurrent Ovarian Cancer or Other Recurrent Mucin-16 Expressing (MUC16+) Cancers 06/20/2018 INTERVENTIONAL not-comparable 3,034.75 0 Gynecologic Extramammary Paget's Disease 06/20/2018 OBSERVATIONAL not-comparable 3,034.75 0 Vaginal Microbiome Exposure and Immune Responses in C-section Infants 06/26/2018 INTERVENTIONAL not-comparable 3,028.75 0 CFI-402257 in Combination With Paclitaxel in Patients With Advanced/Metastatic HER2-Negative Breast Cancer 06/26/2018 INTERVENTIONAL not-comparable 3,028.75 0 Monitoring Response to Neoadjuvant Chemotherapy in HER2 Negative Breast Cancer Using High-speed MR Spectroscopic Imaging 06/26/2018 OBSERVATIONAL not-comparable 3,028.75 0 Impact of Pegfilgrastim on Trastuzumab Anti-tumor Effect and ADCC in Operable HER2+ Breast Cancer Breast Cancer 06/27/2018 INTERVENTIONAL not-comparable 3,027.75 0 Talking to Employers and Medical Staff About Breast Cancer Treatment and Your Job 06/28/2018 INTERVENTIONAL not-comparable 3,026.75 0 Chronic Effect of Fasting 06/29/2018 INTERVENTIONAL not-comparable 3,025.75 0 Breast Aesthetics by Three Dimensional Measures 07/06/2018 OBSERVATIONAL not-comparable 3,018.75 0 Study of the Safety and Effectiveness of Motiva Implants® 07/09/2018 INTERVENTIONAL not-comparable 3,015.75 0 Phase II Multi-center Trial Evaluating 5 Fraction Stereotactic Partial Breast Irradiation Using Gammapod 07/10/2018 INTERVENTIONAL not-comparable 3,014.75 0 Accelerated Partial Breast Irradiation With IMRT in Early Breast Cancer 07/11/2018 INTERVENTIONAL not-comparable 3,013.75 0 The Effect of Membrane Sweeping on the Delivery Time and the Need of Induction in Term Pregnancy 07/19/2018 INTERVENTIONAL not-comparable 3,005.75 0 Phase 1b Study of Pegylated Liposomal Doxorubicin and Pembrolizumab in Endocrine-resistant Breast Cancer 07/19/2018 INTERVENTIONAL not-comparable 3,005.75 0 Baby's First Years 07/20/2018 INTERVENTIONAL not-comparable 3,004.75 0 Neoadjuvant Treatment of HER2 Positive Early High-risk and Locally Advanced Breast Cancer 07/23/2018 INTERVENTIONAL not-comparable 3,001.75 0 Mineral Status in Pregnant Women 07/26/2018 OBSERVATIONAL not-comparable 2,998.75 0 A Comparison of Platinum-based Therapy With TSR-042 and Niraparib Versus Standard of Care (SOC) Platinum-based Therapy as First-line Treatment of Stage III or IV Nonmucinous Epithelial Ovarian Cancer 07/27/2018 INTERVENTIONAL not-comparable 2,997.75 0 Serial Imaging of the Novel Radiotracer [^18F] FLuorthanatrace ([^18F] FTT) by PET/CTF 07/27/2018 INTERVENTIONAL not-comparable 2,997.75 0 Non-contrast DWI for Supplemental Screening 07/31/2018 OBSERVATIONAL not-comparable 2,993.75 0 A Culturally-tailored Personalized Nutrition Intervention in South Asian Women at Risk of Gestational Diabetes 07/31/2018 INTERVENTIONAL not-comparable 2,993.75 0 SBRT and Atezolizumab in the Management of Recurrent, Persistent, or Metastatic Cervical Cancer 08/03/2018 INTERVENTIONAL not-comparable 2,990.75 0
Source U.S. National Library of Medicine, ClinicalTrials.gov API v2 · official record · retrieved 10/10/2026 · upstream last modified 10/10/2026
Licence United States government work; public domain unless the source record says otherwise. Source: U.S. National Library of Medicine
Required notice Study records are informational and do not provide diagnosis, treatment advice, or an assessment of individual risk. What we add We compute Vuga Group, Change Status, Recency Days, Research Attention Score using the documented compute method. · methodology